Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nmni.2020.100689 http://scihub22266oqcxt.onion/10.1016/j.nmni.2020.100689 32355564!7192073!32355564     free     free     free       New+Microbes+New+Infect 2020 ; 35 (?): 100689 Nephropedia Template TP {{tp|p=32355564|t=2020. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome |pdf=|usr=}}{{32355564}} gab.com Text Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome JO: New Microbes New Infect http://www.kidney.de/pget.php?&tw=1&pmid=32355564 #FOAvip We propose a likely contribution to severe COVID-19 morbidity by extracellular DNA in neutrophil extracellular traps (NETs). Dornase alfa degrades extracellular DNA to reduce mucus rigidity and accumulation, and was associated with respiratory improvement in a first patient. Dornase alfa should be considered for clinical trials in treatment of severe COVID-19. Twit Text FOAVip Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome ????New Microbes New Infect http://www.kidney.de/pget.php?&tw=1&pmid=32355564 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32355564 #FOAvip English Wikipedia <ref>{{Cite pmid|32355564}}</ref> Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome #MMPMID32355564 Earhart AP; Holliday ZM; Hofmann HV; Schrum AG New Microbes New Infect 2020[May]; 35 (?): 100689 PMID32355564show ga We propose a likely contribution to severe COVID-19 morbidity by extracellular DNA in neutrophil extracellular traps (NETs). Dornase alfa degrades extracellular DNA to reduce mucus rigidity and accumulation, and was associated with respiratory improvement in a first patient. Dornase alfa should be considered for clinical trials in treatment of severe COVID-19. ?Consideration of dornase alfa for the treatment of severe COVID-19 acu(epmc).pdf DeepDyve Pubget Overpricing